GlycoMimetics A Buy On Nearing Trial Enrollment Completion

jarun011/iStock via Getty Images
If I had the kind of money that enabled me to buy an entire small biotechnology company today, I would buy GlycoMimetics (GLYC). The company has a market capitalization of just around $110 million, but things will be different…

Click here to view the original article.